James Panek
Director/Board Member at SUTRO BIOPHARMA, INC.
Net worth: - $ as of 29/04/2024
James Panek active positions
| Companies | Position | Start | End |
|---|---|---|---|
| SUTRO BIOPHARMA, INC. | Director/Board Member | 06/01/2020 | - |
| Independent Dir/Board Member | 06/01/2020 | - | |
| Cho Plus, Inc. | Chief Operating Officer | - | - |
Career history of James Panek
Former positions of James Panek
| Companies | Position | Start | End |
|---|---|---|---|
| DIADEXUS, INC. | Director/Board Member | 31/12/2006 | 31/12/2010 |
| Chief Executive Officer | 31/12/2009 | 31/12/2010 | |
| Director of Finance/CFO | 31/12/2009 | 31/12/2010 | |
| President | 31/12/2009 | 31/12/2010 | |
diaDexus, Inc. /Old/
 diaDexus, Inc. /Old/ Medical SpecialtiesHealth Technology diaDexus is a privately held biotechnology company that is focused on the discovery, development and commercialization of novel, patent protected diagnostic products with high clinical value. diaDexus makes a difference by developing innovative products with clinical value to address significant unmet medical needs in the cardiovascular field. | Director/Board Member | 09/08/2010 | 31/10/2010 |
VaxGen, Inc.
 VaxGen, Inc. BiotechnologyHealth Technology VaxGen, Inc. is a biopharmaceutical company, owns a state-of-the-art biopharmaceutical manufacturing facility that can be used to make cell culture or microbial biologic products. The company has ended all product development activities and sold or otherwise terminated its drug development programs. It is seeking to maximize the value of its remaining tangible and intangible assets through a transaction or series of transactions, including the sale of the manufacturing facility. The company was founded on November 01, 1995 and is headquartered in South San Francisco, CA. | Comptroller/Controller/Auditor | 31/12/2006 | 31/12/2009 |
| Director/Board Member | 31/12/2006 | 31/12/2009 | |
| Director of Finance/CFO | 31/12/2006 | 31/12/2009 | |
| Corporate Officer/Principal | 31/01/2002 | 31/12/2005 | |
| President | 31/12/2006 | 31/12/2009 | |
| CELLTRION, INC. | Chief Executive Officer | 31/12/2001 | 31/12/2005 |
| Chairman | 31/12/2001 | 31/12/2005 | |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Corporate Officer/Principal | 31/12/1981 | 31/12/2000 |
Training of James Panek
| University of Michigan | Graduate Degree |
Statistics
International
| United States | 8 |
| South Korea | 2 |
Operational
| Director/Board Member | 4 |
| Director of Finance/CFO | 2 |
| Corporate Officer/Principal | 2 |
Sectoral
| Health Technology | 7 |
| Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 2 |
|---|---|
| SUTRO BIOPHARMA, INC. | Health Technology |
| CELLTRION, INC. | Health Technology |
| Private companies | 5 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
VaxGen, Inc.
VaxGen, Inc. BiotechnologyHealth Technology VaxGen, Inc. is a biopharmaceutical company, owns a state-of-the-art biopharmaceutical manufacturing facility that can be used to make cell culture or microbial biologic products. The company has ended all product development activities and sold or otherwise terminated its drug development programs. It is seeking to maximize the value of its remaining tangible and intangible assets through a transaction or series of transactions, including the sale of the manufacturing facility. The company was founded on November 01, 1995 and is headquartered in South San Francisco, CA. | Health Technology |
diaDexus, Inc. /Old/
diaDexus, Inc. /Old/ Medical SpecialtiesHealth Technology diaDexus is a privately held biotechnology company that is focused on the discovery, development and commercialization of novel, patent protected diagnostic products with high clinical value. diaDexus makes a difference by developing innovative products with clinical value to address significant unmet medical needs in the cardiovascular field. | Health Technology |
Diadexus, Inc.
 Diadexus, Inc. BiotechnologyHealth Technology Diadexus, Inc. engages in the research, development, and commercialization of pharmaceutical products. Its portfolio intends to treat cardiovascular diseases. The company was founded on November 27, 1995 and is headquartered in South San Francisco, CA. | Health Technology |
| Cho Plus, Inc. |
- Stock Market
- Insiders
- James Panek
- Experience
